Clearmind Medicine Inc. (NASDAQ:CMND) Sees Large Increase in Short Interest

Clearmind Medicine Inc. (NASDAQ:CMND) was the target of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 316,600 shares, an increase of 45.6% from the October 15th total of 217,400 shares. Based on an average trading volume of 377,300 shares, the short-interest ratio is currently 0.8 days. Currently, 10.5% of the shares of the stock are sold short.

Clearmind Medicine Trading Down 8.8 %

CMND traded down $0.13 during midday trading on Friday, hitting $1.34. The company had a trading volume of 284,485 shares, compared to its average volume of 1,358,733. Clearmind Medicine has a twelve month low of $0.92 and a twelve month high of $6.80. The firm’s 50-day simple moving average is $1.37 and its 200-day simple moving average is $1.36. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 0.01.

Clearmind Medicine (NASDAQ:CMND) last issued its quarterly earnings results on Monday, September 16th. The company reported ($0.59) EPS for the quarter.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Clearmind Medicine stock. AdvisorShares Investments LLC lifted its holdings in Clearmind Medicine Inc. (NASDAQ:CMND) by 14.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 128,641 shares of the company’s stock after purchasing an additional 15,948 shares during the quarter. AdvisorShares Investments LLC owned 7.60% of Clearmind Medicine worth $214,000 as of its most recent SEC filing. Institutional investors own 96.05% of the company’s stock.

Clearmind Medicine Company Profile

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.